Quarterfinals
Win or go home
England: IV Iron and MI in ESKD
The Three Lions have done it. After a tough Quarterfinal match against The Netherlands, England enters the Semifinals in a great position.
The Netherlands took an early lead with players favoring polypharmacy. England hung tough and in the end, sailed smoothly into the Semifinals. The CVRM community continues to favor IV iron therapy in dialysis patients, especially if such an intervention reduces the number one cause of mortality in this patient population.
Denmark: SGLT2i and kidney stones
SGLT2i remain one of the hottest topics in the CVRM space, but it had a tough fight against Team Argentina (CKD post-nephrectomy). Early in this Quarterfinal match Denmark and Argentina were neck-and-neck. Denmark started pulling away after the 56th vote and never looked back.
Denmark enters the Semifinals with a tough matchup against England. Can the SGLT2i streak continue or will it meet its match against IV iron?
Brasil: 0.9% saline v balanced solutions in critically ill patients
Brasil has the unique distinction of a) the only non-European team remaining in the NephroWorldCup Tournament and b) one of two semifinal teams that isn't focused on SGLT2i (England is the other). Brasil had an easy time against Portugal even though the latter had a focus on POCUS 😄.
Brasil matches against one of the strongest competitors in the NephroWorldCup....Spain and its combination of SGLT2i and mineralocorticoid receptor antagonist.
Spain: SGLT2i, MRA, or both to reduce albuminuria
Perhaps to no one's surprise Spain cruised into the Semifinals. Battling Canada and its hybrid cardiology-renal-endocrine clinic, Spain showed that treatment itself has more impact to the CVRM community than the delivery of said treatment.
Spain now faces a formidable opponent in Brasil and its look at balanced solutions. Will this be the match that defeats an SGLT2i team?